Results 101 to 110 of about 189,673 (176)

A prospective analysis of management and outcomes of worsening heart failure in the outpatient setting

ESC Heart Failure, EarlyView.
Abstract Aims There is growing recognition of the burden and prognostic significance of WHF treated in the outpatient setting. However, there is currently a lack of prospective real‐world data in this area of HF care. This study aims to analyse the natural history of outpatient WHF.
Joseph McCambridge, Fiyinfoluwa Fabamwo, Shadia Taha, Dermot McCaffrey, Matthew Barrett, Ciara Mahon, Kenneth McDonald   +6 more
wiley   +1 more source

A novel treatment score (QUAD score) to promote treatment optimization in heart failure with a reduced ejection fraction

ESC Heart Failure, EarlyView.
The QUAD score was developed to promote adherence to clinical practice guidelines for patients with heart failure and a reduced left ventricular ejection fraction <50%. In newly diagnosed patients who had completed therapy titration, we found that patients with an excellent QUAD score had a significant reduction in the risk of mortality or ...
Henry Oluwasefunmi Savage, Jason N. Dungu, Anthony Dimarco, Brian Li, Samantha Langley, Jonathan Kojo Amoah, Paraic Cliffe, Archana Ganapathy, Peter Watters, Patricia Campbell, Nicola Melarkey, Simon Duckett, Sean Davies, Matthew Dewhurst, Karen Hann, Louise Clayton, Rhys Williams, Victoria Ruszala, Teresa Onwere‐Tan, Fozia Zahir Ahmed, Ibrahim Arosi, Kimberly Gray, Mark C. Petrie, John G.F. Cleland   +23 more
wiley   +1 more source

Nurse‐coordinated multidisciplinary comprehensive heart failure management programme: A propensity‐matched trial

ESC Heart Failure, EarlyView.
Abstract Aims Despite therapeutic advancements, the prognosis of heart failure (HF) remains poor, with high rates of mortality and readmission, particularly following a HF exacerbation. This study aimed to evaluate the effects of a nurse‐coordinated multidisciplinary comprehensive HF management programme on HF patients.
Cecilia Miu‐Ching Chan, Polly Wai‐Chi Li, Derek Pok‐Him Lee, Esmond Yan‐Hang Fong, Ivy Sin‐Yee Ng, Samantha Ki‐Man Chiu, Clara Woon‐Shan Fok, Frederick Kin‐Wa Li, Shirley Ka‐Wai Lee, Karen K. Y. Ho, Wilson Y. S. Leung, Cathy Cheuk‐Sum Chan, Cindy Yiu‐Ning Tsang, Michael Kang‐Yin Lee   +13 more
wiley   +1 more source

Mapping of current practices of palliative care for patients with heart failure throughout Europe: A scoping review

ESC Heart Failure, EarlyView.
Abstract Heart failure (HF) is a growing health and societal challenge in Europe, due to an increasingly elderly, frail and multimorbid population. Many patients with HF experience a high burden of complex and multidimensional symptoms leading to a reduced quality of life and significant socioeconomic impact. Despite proven benefits, the integration of
Tania Pastrana, Matthew Grant, Paula Hidalgo Andrade, Daniele Marelli, Klaus Witte, Geert‐Jan Geersing, Carla Ripamonti, Roman Rolke, Marco Metra, Matteo Pagnesi, Everlien De Graaf, Cosimo Chelazzi, on behalf of the RAPHAEL consortium   +12 more
wiley   +1 more source

A heart failure network model to improve outcome and trans‐sectoral guideline‐directed medical treatment utilization

ESC Heart Failure, EarlyView.
Abstract Aims Heart failure (HF) is a major cause of hospitalization, mortality and healthcare costs. Reducing its socioeconomic burden is a key global public health priority. HF networks are recommended to improve screening and management of HF patients.
Christina Paitazoglou, Dominik Jurczyk, Matthias Mezger, Felicitas Lemmer, Bernhard Schwaab, Patricia Grube, Thomas Helms, Bettina Zippel‐Schultz, Buntaro Fujita, Roland Tilz, Thomas Stiermaier, Christian Frerker, Stephan Ensminger, Ingo Eitel   +13 more
wiley   +1 more source

Sex‐based differences in heart failure management and outcomes: Insights from the French‐DataHF cohort

European Journal of Heart Failure, EarlyView.
Sex differences in heart failure (HF) management and outcomes in the French‐DataHF cohort. CI, confidence interval; HFH, heart failure hospitalization; HR, hazard ratio; IPW, inverse probability weighting; KM, Kaplan–Meier; LD, loop diuretic; RAS, renin–angiotensin system; RASi, renin–angiotensin system inhibitor.
Guillaume Baudry, Ouarda Pereira, François Roubille, Marc Villaceque, Thibaud Damy, Kevin Duarte, Philippe Tangre, Nicolas Girerd   +7 more
wiley   +1 more source

The Intention of Primary Health Nurses to Participate in Internet Plus Nursing Service: Cross-Sectional Survey. [PDF]

JMIR Nurs
Xu B, Li S, Chen K, Ding L, Liu L.
europepmc   +1 more source

Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC

European Journal of Heart Failure, EarlyView.
Barriers and solutions to referral and therapy implementation in advanced heart failure. EMR, electronic medical record; HF, heart failure; HT, heart transplantation; ICARe‐HF, integrated care for advanced heart failure; LVAD, left ventricular assist device; MCS, mechanical circulatory support; OMT, optimal medical therapy; RCT, randomized controlled ...
Guillaume Baudry, Maria Generosa Crespo‐Leiro, Clément Delmas, Federica Guidetti, Marta Jimenez‐Blanco Bravo, Federica Valente, Maja Cikes, Nicolas Girerd, Finn Gustafsson, Gianluigi Savarese, Linda W. van Laake, Loreena Hill, Anne Kathrine Skibelund, Andreas Zuckermann, Marco Metra, Kevin Damman   +15 more
wiley   +1 more source

A study of family care needs after pediatric congenital heart disease interventions based on the KANO model. [PDF]

BMC Cardiovasc Disord
Tang H, Zhang W, Jing M, Zhou S, Xu J.
europepmc   +1 more source

Low‐dose digoxin improves cardiac function in patients with heart failure, preserved ejection fraction and atrial fibrillation – the RATE‐AF randomized trial

European Journal of Heart Failure, EarlyView.
Summary of the change in left ventricular systolic and diastolic parameters from baseline to 12 months in patients with permanent atrial fibrillation (AF) and a left ventricular ejection fraction (LVEF) ≥50%. P‐values indicate the significance of the adjusted mean difference of the parameters at 12 months between the beta‐blocker and digoxin arm. E/e′,
Karina V. Bunting, Asgher Champsi, Simrat K. Gill, Khalil Saadeh, A. John Camm, Mary Stanbury, Sandra Haynes, Jonathon N. Townend, Richard P. Steeds, Dipak Kotecha, on behalf of the RAte control Therapy Evaluation in Permanent Atrial Fibrillation (RATE‐AF) Trial Group   +10 more
wiley   +1 more source